Revolution Medicines Inc [RVMD] stock is trading at $37.81, down -1.46%. An important factor to consider is whether the stock is rising or falling in short-term value. The RVMD shares have gain 3.76% over the last week, with a monthly amount drifted -8.03%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 15, 2025, when Goldman initiated its Buy rating and assigned the stock a price target of $65. Previously, Needham reaffirmed its Buy rating on July 16, 2024, and elevated its price target to $62. On July 12, 2024, Barclays initiated with a Overweight rating and assigned a price target of $52 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $63 on July 08, 2024. Needham reiterated its recommendation of a Buy and raised its price target to $46 on April 12, 2024. Raymond James upgraded its rating to Strong Buy for this stock on April 10, 2024, and upped its price target to $48. In a note dated March 11, 2024, Piper Sandler initiated an Overweight rating and provided a target price of $43 on this stock.
Revolution Medicines Inc [RVMD] stock has fluctuated between $29.17 and $62.40 over the past year. Currently, Wall Street analysts expect the stock to reach $68 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $37.81 at the most recent close of the market. An investor can expect a potential return of 79.85% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -3.02%, Pretax Profit Margin comes in at -2.67%, and Net Profit Margin reading is -2.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.37 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 37.20 points at the first support level, and at 36.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.93, and for the 2nd resistance point, it is at 40.06.
Ratios To Look Out For
For context, Revolution Medicines Inc’s Current Ratio is 13.46. On the other hand, the Quick Ratio is 13.46, and the Cash Ratio is 2.1.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Jun 20 ’25 when 1912.0 shares were sold. Officer, JEFFREY TODD CISLINI completed a deal on Jun 20 ’25 to buy 1912.0 shares. Meanwhile, Chief Operating Officer Horn Margaret A sold 3510.0 shares on Jun 16 ’25.
